Insider Cluster (2 insiders) ·Filed Jul 8, 2026

MIRM

Mirum Pharmaceuticals, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed2mo ago
Insider cluster: 2 insiders, $707K total
Actionable Insight • Neutral

Insider selling is immaterial relative to market cap and likely reflects routine personal liquidity or tax planning. No directional signal for MIRM shares. Monitor for larger insider transactions or accompanying corporate events (e.g., earnings, M&A) that could change the context.

DirectionNeutral
Confidencehigh
Horizonimmediate
Final — all horizons settled through T+60d
MIRM ▼ -33.51% at T+60d
NEUTRAL call ✗ call lost -33.51% · α vs SPY -35.83% · entry $128.57 → $85.48
Entry anchored
Jul 7, 03:59 PM ET
via exchange tick
T+1d
-0.68%
call -0.68% · α -1.52%
$127.70
settled 3mo ago
T+5d
-5.97%
call -5.97% · α -6.84%
$120.89
settled 3mo ago
T+20d
-17.72%
call -17.72% · α -20.99%
$105.79
settled 8w ago
T+60d
-33.51%
call -33.51% · α -35.83%
$85.48
settled 2d ago

Price Chart

Loading chart...

Executive Summary

Two Mirum Pharmaceuticals insiders (CFO Eric Bjerklholt and SVP/Global Controller Jolanda Howe) sold a combined $707K in open-market shares over a one-week window. The total sales represent less than 0.01% of the $7.8B market cap, making the cluster economically trivial and uninformative for stock direction.

Key Financial Metrics

Direction
selling
Total Value
$707.0K
Insiders
2

Key Facts

  • CFO Eric Bjerklholt sold 3,100 shares at $121.67 on July 6, 2026, worth ~$380K
  • SVP/Global Controller Jolanda Howe sold 2,718 shares at $120.00 on July 1, 2026, worth ~$327K
  • Total insider sales of $707K represent less than 0.01% of MIRM's $7.8B market cap
  • No other insiders traded; cluster is small and isolated

Financial Impact

Negligible — $707K in insider sales, <0.01% of market cap

dilutioninsider ownership

Risk Factors

  • Minimal from this filing; no material risk indicated

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
95% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-MIRM-1783576941195
16 reports for MIRM
Performance horizon
80% Hit rate 4 of 5 directional calls best @ T+20▲ +28.29%Jun 11, 2026
Filters
Rows
Reports for MIRM — sortable, filterable
TypeNow
Aug 19, 2026
6w ago
Insider Cluster
NEUTRAL ★ 3/10
$102.24 $98.82▼ −3.35%▼ −1.39%$82.93 (−18.89%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 3/10
$98.97 $100.61▲ +1.66%▲ +3.55%$82.93 (−16.21%)
Aug 11, 2026
7w ago
Insider Cluster
BEARISH ★ 5/10
$98.97 $100.61▼ −1.66%▼ −3.55%$82.93 (+16.21%)
Aug 10, 2026
7w ago
144
NEUTRAL ★ 3/10
$98.23 $98.30▲ +0.07%▲ +1.13%$82.93 (−15.58%)
Aug 5, 2026
8w ago
8-K
MIXED ★ 6/10
$94.12 $100.63▲ +6.92%▲ +6.32%$82.93 (−11.88%)
Jul 8, 2026
12w ago
Insider Cluster
NEUTRAL ★ 2/10
$128.57 $105.79▼ −17.72%▼ −20.99%$82.93 (−35.50%)
Jun 11, 2026
16w ago
Institutional Cluster
BULLISH ★ 6/10
$99.54 $127.70▲ +28.29%▲ +26.40%$82.93 (−16.69%)
Jun 10, 2026
16w ago
Insider Cluster
NEUTRAL ★ 3/10
$94.00 $127.70▲ +35.85%▲ +32.23%$82.93 (−11.78%)
Jun 2, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$91.84 $125.59▲ +36.76%▲ +37.76%$82.93 (−9.70%)
Jun 1, 2026
17w ago
144
NEUTRAL ★ 3/10
$92.17 $120.46▲ +30.69%▲ +32.26%$82.93 (−10.02%)
Showing 10 of 16

US Market Status

Market Closed — Opens Mon (65h 25m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access
Report published Jul 9, 2026